Investment in general practice for the 2021 to 2022 financial year to the 2025 to 2026 financial year
The data includes overall spending as well as statistics for patient groups, and in general, total spend has increased.
In this page
Key facts
In 2025 to 2026 there was an increase in the total investment in GP practices of £10.5 million compared to the published 2024 to 2025 figures.
Table 2a: summary of reported investment in general practice 2021 to 2022 to 2025 to 2026, Wales
| 2021 to 2022 | 2022 to 2023 | 2023 to 2024 | 2024 to 2025 | 2025 to 2026 | |
| Global sum or Minimum Practice Income Guarantee (MPIG) | £322,512,000 | £352,792,000 | £386,335,000 | £435,688,000 | £453,304,000 |
| Quality | £44,076,000 | £31,357,000 | £20,695,000 | £20,125,000 | £20,419,000 |
| Direct Services (GMS) | £33,239,000 | £29,483,000 | £28,637,000 | £29,034,000 | £27,189,000 |
| National Services (GMS) | £4,219,000 | £4,595,000 | £5,304,000 | £6,016,000 | £5,930,000 |
| Local Services (GMS) | £17,837,000 | £13,034,000 | £15,515,000 | £15,375,000 | £16,821,000 |
| Total supplementary services | £55,295,000 | £47,112,000 | £49,456,000 | £50,425,000 | £49,490,000 |
| Premises | £41,655,000 | £41,390,000 | £41,502,000 | £41,074,000 | £40,443,000 |
| PCO Administered Funds | £30,665,000 | £35,836,000 | £40,732,000 | £35,224,000 | £38,194,000 |
| Out of Hours (incl. OOH Development Fund) | £37,148,000 | £37,986,000 | £41,880,000 | £50,469,000 | £49,497,000 |
| IT (incl. centrally funded IM and T) | £15,024,000 | £16,248,000 | £17,708,000 | £19,292,000 | £23,009,000 |
| Total Other Payments | £124,492,000 | £131,460,000 | £141,822,000 | £146,059,000 | £151,143,000 |
| Subtotal | £546,375,000 | £562,721,000 | £598,308,000 | £652,297,000 | £674,806,000 |
Country Specific Investment | |||||
| National Primary Care fund: direct practice payments | £4,858,000 | £4,858,000 | £4,858,000 | £4,858,000 | £4,858,000 |
| National Primary Care fund: Investment on behalf of GP practices | £22,412,000 | £22,412,000 | £22,412,000 | £22,412,000 | £22,412,000 |
| Total Country Specific Investment | £27,270,000 | £27,270,000 | £27,270,000 | £27,270,000 | £27,270,000 |
| Total Net of Dispensing | £573,645,000 | £589,991,000 | £625,578,000 | £679,567,000 | £702,076,000 |
| Cost of Dispensing Fees (incl. DSQS )[footnote1] | £11,906,000 | £14,841,000 | £13,557,000 | £13,845,000 | £12,161,000 |
| Total Investment Excluding Reimbursement of Drugs[footnote2] | £585,551,000 | £604,832,000 | £639,135,000 | £693,412,000 | £714,237,000 |
| Reimbursement of Dispensed Drugs (incl. vat allowance and discounts) | £42,232,000 | £45,251,000 | £45,203,000 | £46,156,000 | £35,832,000 |
| Total Spend[footnote3] | £627,783,000 | £650,083,000 | £684,338,000 | £739,568,000 | £750,069,000 |
Note
Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
National primary care fund expenditure: prior to 2017 to 2018, was only added as a footnote. Since Covid, rules were relaxed on submission of a return to WG for this Fund, so no change to figures.
Table 2b: reported investment in general practice 2025 to 2026, Wales
| £ Outturn | |
|---|---|
| Global sum | 451,892,000 |
| MPIG correction factor | 1,412,000 |
| Total global sum and MPIG | 435,304,000 |
| Quality aspiration payments | 8,086,000 |
| Quality achievement payments | 5,814,000 |
| Quality Assurance Improvement Framework (QAIF) | 6,519,000 |
| Total quality | 20,419,000 |
| Direct services | 27,189,000 |
| National services | 5,930,000 |
| Local services | 16,821,000 |
| Total supplementary services | 49,940,000 |
| Premises | 40,443,000 |
| PCO administered funds | 38,194,000 |
| Out of hours | 49,497,000 |
| Information Management and Technology (IM and T) | 23,009,000 |
| Total other payments | 151,143,000 |
| Subtotal | 673,806,000 |
| £ Outturn | |
|---|---|
| National primary care fund: direct practice payments | 4,858,000 |
| National primary care fund: investment on behalf of GP practices | 22,412,000 |
| Total country specific investment | 27,270,000 |
| £ Outturn | |
|---|---|
| Total net of dispensing | 702,076,000 |
| Dispensary Services Quality Scheme (DSQS) | 612,000 |
| Cost of dispensing fees[footnote1] | 11,549,000 |
| Total of all dispensing fees | 12,161,000 |
| £ Outturn | |
|---|---|
| Total investment excluding reimbursement of drugs[footnote2] | 714,237,000 |
| Reimbursement of dispensed drugs (including VAT allowance and discounts) | 35,832,000 |
| Total spend | 750,069,000 |
Note
Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
National primary care fund expenditure: prior to 2017 to 2018, was only added as a footnote. Since COVID-19, rules were relaxed on submission of a return to Welsh Government for this fund, so no change to figures.
Table 2c: Supplementary Information 2025 to 2026, Wales
| Direct enhanced services | £ Outturn |
|---|---|
| Asylum seekers and refugees | 10,000 |
| Care of diabetes | 4,143,000 |
| Care homes | 4,312,000 |
| Childhood vaccination and immunisation scheme | 3,763,000 |
| Extended opening times | 17,000 |
| Homeless | 195,000 |
| Influenza and pneumococcal immunisations scheme | 8,064,000 |
| Learning disabilities | 177,000 |
| Mental health | 26,000 |
| Minor surgery fees | 3,721,000 |
| Services for violent patients | 133,000 |
| Oral anticoagulation with Warfarin | 2,430,000 |
| Gender identity | 322,000 |
| Complex multi morbidity and frailty | -124,000 |
| Total direct supplementary services | 27,189,000 |
| £ Outturn | |
|---|---|
| Seniority | 3,256,000 |
| Doctors retainer scheme payments | 441,000 |
| Locum allowances: adoptive, paternity and maternity | 2,958,000 |
| Locum allowances: sickness | 1,751,000 |
| Locum allowances: suspended doctors | 183,000 |
| Locum allowances: other locum payments | 160,000 |
| Appraiser costs | 0 |
| Recruitment and retention (including 'golden hello') | 0 |
| Primary care development scheme | 1,030,000 |
| Partnership premium | 8,410,000 |
| Designated area allowance | 0 |
| Initial practice allowance | 0 |
| Assistant's allowance | 0 |
| Associate allowance | 0 |
| Access payments (new for 2021 to 2022) | 4,085,00 |
| Other | 15,920,000 |
| Total PCO administered funds | 38,194,000 |
| £ Outturn | |
|---|---|
| GP support costs | 0 |
| Managed practice costs - managed practices | 12,649,000 |
| Managed practice costs - managing practices | 0 |
| Primary care initiatives | 1,434,000 |
| GP practice training | 177,000 |
| Salaried GP costs | 0 |
| Other approved PCO administered costs | 1,660,000 |
| Total other payments | 15,920,000 |
Note
Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
Footnotes
[1] For items dispensed and personally administered by Dispensing Doctors and Prescribing Doctor practices.
[2] Total Investment Excluding Reimbursement of Drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.
[3] For 2017 to 2018 and 2018 to 2019 includes costs for one APMS contract.